Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from dorsaVi Limited ( (AU:DVL) ).
dorsaVi Limited has announced a new commercial research collaboration with prominent US Foot and Ankle Physician, Dr. Chirag Patel, known for his work with professional athletes and ESPN. The project, valued at $46,750 USD, will utilize dorsaVi’s wearable sensors and advanced AI to study athlete movements, aiming to identify injury risks. The study, set for the first half of 2025, could lead to further collaborations based on its success. The initiative underscores dorsaVi’s commitment to data integrity, with plans for blockchain integration to secure data and reinforce trust among stakeholders.
More about dorsaVi Limited
dorsaVi Limited is a global leader in FDA-cleared wearable sensor technology and human movement analysis. The company is renowned for its expertise in lower limb products within the US sporting and clinical markets, leveraging advanced AI and algorithmic capabilities to enhance athlete performance and safety.
YTD Price Performance: 0.0%
Average Trading Volume: 1,959,138
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$7.31M
For a thorough assessment of DVL stock, go to TipRanks’ Stock Analysis page.
